| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2007 | EP1804784A1 The treatment of inflammatory bowel disease |
| 07/11/2007 | EP1804783A1 Method of using adapalene in acne maintenance therapy |
| 07/11/2007 | EP1804782A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 07/11/2007 | EP1804781A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 07/11/2007 | EP1804780A1 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 07/11/2007 | EP1804779A1 Use of an mtor inhibitor in treatment of uterine leiomyoma |
| 07/11/2007 | EP1804778A1 Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract |
| 07/11/2007 | EP1804777A1 Pharmaceutical composition comprising diclofenac |
| 07/11/2007 | EP1804769A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 07/11/2007 | EP1804768A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 07/11/2007 | EP1804765A2 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 07/11/2007 | EP1804761A2 Compositions and methods for treatment of skin discoloration |
| 07/11/2007 | EP1804582A1 Polymorphic forms of tadalafil |
| 07/11/2007 | EP1804579A1 Process for making antimicrobial polymer articles |
| 07/11/2007 | EP1741425A4 Novel antiviral pharmaceutical composition |
| 07/11/2007 | EP1686983B1 Use of pentadienoic acid derivates for treatement of hyperuricemia |
| 07/11/2007 | EP1664024B1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 07/11/2007 | EP1660495B1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 07/11/2007 | EP1622899B1 Pioglitazone sulfate, pharmaceutical compositions and their use |
| 07/11/2007 | EP1608646B1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 07/11/2007 | EP1596874B1 Method for treating liver cancer by intrahepatic administration of nemorubicin |
| 07/11/2007 | EP1592428B1 New crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n- 6-(1,1-dioxo-1lamda-6 -thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl -n-methyl-isobutyramide |
| 07/11/2007 | EP1553832B1 Cell separation compositions and methods |
| 07/11/2007 | EP1551395B1 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 07/11/2007 | EP1536763B1 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent |
| 07/11/2007 | EP1530471B1 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1461361B1 Negatively charged polysaccharide derivable from aloe vera |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1458398A4 Antibiotic formulation and a method of making this formulation |
| 07/11/2007 | EP1408961B1 2 pyrrolidone derivatives as prostanoid agonists |
| 07/11/2007 | EP1366021B1 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 07/11/2007 | EP1357917B1 Use of carbohydrates for eliminating intestinal infections in animals |
| 07/11/2007 | EP1355886B1 Fused heterocyclic compounds |
| 07/11/2007 | EP1309597B1 Polymorphs of an epothilone analog |
| 07/11/2007 | EP1307198A4 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 07/11/2007 | EP1303265B1 Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1206284B1 Method for delivery of therapeutic agents using a solution of dextrin |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1179184B1 Identifying material from a breast duct |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1135128B1 Novel method of treatment |
| 07/11/2007 | EP1073429B1 Aerosol formulations of salmeterol xinafoate |
| 07/11/2007 | EP1043022B1 Sodium ion absorption inhibitors and sodium ion excretion accelerators as preventive and therapeutic agents for diseases resulting from excessive intake of common salt |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | EP0998291B1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/11/2007 | EP0927214B1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages |
| 07/11/2007 | EP0857208B1 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 07/11/2007 | EP0815214B1 Dna molecules, preparation thereof and use thereof in gene therapy |
| 07/11/2007 | CN1997659A D-homo-17-chloro-16(17)en steroids |
| 07/11/2007 | CN1997657A Therapeutic heparins and their binding to interleukins 4 and 5, and PECAM-1 |
| 07/11/2007 | CN1997655A Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 07/11/2007 | CN1997651A Oxidative degradation products of atorvastatin calcium |
| 07/11/2007 | CN1997649A Inhibitors of histone deacetylase |
| 07/11/2007 | CN1997648A Polymorphic forms of methyl(+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-C]pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide |
| 07/11/2007 | CN1997647A Clopidogrel salt and polymorphic forms thereof |
| 07/11/2007 | CN1997646A Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase |
| 07/11/2007 | CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 07/11/2007 | CN1997644A Aryl substituted purine analogues |
| 07/11/2007 | CN1997643A Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 07/11/2007 | CN1997642A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/11/2007 | CN1997641A Diarylamine derivatives as calcium channel blockers |
| 07/11/2007 | CN1997638A 1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP1-B inhibitors |
| 07/11/2007 | CN1997635A Dihydrobenzofuranyl alkanamine derivatives as 5HT2C agonists |
| 07/11/2007 | CN1997633A Substituted triazoles as modulators of PPAR and methods of their preparation |
| 07/11/2007 | CN1997632A Geldanamycin and derivatives inhibit cancer invasion and identify novel targets |
| 07/11/2007 | CN1997631A New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 07/11/2007 | CN1997630A New disubstituted phenylpiperidines as modulators of dopamine neurotransmission |
| 07/11/2007 | CN1997629A Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR's) |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/11/2007 | CN1997627A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors |
| 07/11/2007 | CN1997626A Inhibitors of histone deacetylase |
| 07/11/2007 | CN1997625A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors |
| 07/11/2007 | CN1997623A Chemical process and new crystalline form |
| 07/11/2007 | CN1997622A Polycationic compounds and uses thereof |
| 07/11/2007 | CN1997621A Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 07/11/2007 | CN1997619A Phenyl derivatives comprising an acetylene group |
| 07/11/2007 | CN1997618A Compounds with activity at estrogen receptors |
| 07/11/2007 | CN1997401A Preparation of macromolecular conjugates by four-component condensation reaction |
| 07/11/2007 | CN1997400A Conjugated psychotropic drugs and uses thereof |
| 07/11/2007 | CN1997396A Combination therapy of AZD2171 and taxane |
| 07/11/2007 | CN1997395A Drug having regulatory cell ligand contained in liposome |
| 07/11/2007 | CN1997394A Compositions and methods comprising an EGFL7 antagonist for modulating vascular development |
| 07/11/2007 | CN1997380A Composition for antianxiety drug containing vegetable essence ingredient as active ingredient, antianxiety drug employing the composition, and processes for producing these |
| 07/11/2007 | CN1997379A Use of an extract of pueraria tuberosa for the treatment of diabetes type 2 |
| 07/11/2007 | CN1997377A Novel 2'-C methyl nucleoside derivatives |
| 07/11/2007 | CN1997376A Skin conditioning agent |
| 07/11/2007 | CN1997375A Transdermal steroid formulation |
| 07/11/2007 | CN1997374A 雌激素受体调节剂 Estrogen receptor modulators |
| 07/11/2007 | CN1997373A Phycotoxins and uses thereof |
| 07/11/2007 | CN1997372A Manufacturing method of solid dispersion containing itraconazole and pharmaceutical compositions |
| 07/11/2007 | CN1997371A Nicotinamide derivatives and their use as therapeutic agents |
| 07/11/2007 | CN1997370A Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 07/11/2007 | CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/11/2007 | CN1997368A Sns-595 and methods of using the same |
| 07/11/2007 | CN1997367A Composition for the prevention and treatment of allergic inflammatory disease |
| 07/11/2007 | CN1997366A Imidazole and thiazole derivatives as antiviral agents |